Back
Day Range
$9.63
$10.04
52-Week Range
$6.00
$11.31
Volume
7,240,678
50D / 200D Avg
$7.53
/
$7.94
Prev Close
$9.70
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 7.8 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 30.2 | 3.8 |
| Rev Growth 5Y % | 53.6 | 10.0 |
| D/E | — | 0.2 |
Key Takeaways
Revenue grew 53.60% annually over 5 years — strong growth
Net margin of 30.16% shows strong profitability
Generating 327.41M in free cash flow
P/E of 7.80 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 40.50%
Cash machine — converts 124.09% of earnings into free cash flow
Growth
Revenue Growth (5Y)
53.60%
Revenue (1Y)94.10%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC71.40%
Net Margin30.16%
Op. Margin38.98%
Safety
Debt / Equity
N/A
Current Ratio2.06
Interest Coverage4.32
Valuation
P/E Ratio
7.80
P/B RatioN/A
EV/EBITDA7.17
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 94.10% | Revenue Growth (3Y) | 62.47% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 53.60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 874.84M | Net Income (TTM) | 263.86M |
| ROE | N/A | ROA | 51.32% |
| Gross Margin | 97.82% | Operating Margin | 38.98% |
| Net Margin | 30.16% | Free Cash Flow (TTM) | 327.41M |
| ROIC | 71.40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.06 |
| Interest Coverage | 4.32 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 7.80 | P/B Ratio | N/A |
| P/S Ratio | 2.35 | PEG Ratio | -0.02 |
| EV/EBITDA | 7.17 | Dividend Yield | 0.00% |
| Market Cap | 2.06B | Enterprise Value | 2.44B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 874.84M | 450.71M | 331.41M | 270.83M | 157.17M |
| Net Income | 263.86M | -88.88M | -226.54M | -247.12M | -184.06M |
| EPS (Diluted) | 1.21 | -0.43 | -1.18 | -1.33 | -1.03 |
| Gross Profit | 855.76M | 438.23M | 326.75M | 264.23M | 149.91M |
| Operating Income | 340.99M | -2.54M | -103.71M | -148.44M | -177.72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 514.16M | 490.42M | 516.96M | 550.00M | 588.15M |
| Total Liabilities | 633.31M | 966.35M | 972.49M | 844.60M | 695.14M |
| Shareholders' Equity | -119.15M | -475.93M | -455.53M | -294.60M | -106.99M |
| Total Debt | 477.33M | 841.42M | 825.15M | 741.45M | 593.24M |
| Cash & Equivalents | 89.74M | 104.92M | 110.64M | 304.77M | 504.39M |
| Current Assets | 404.35M | 421.97M | 495.97M | 516.50M | 566.14M |
| Current Liabilities | 196.07M | 160.38M | 149.99M | 105.51M | 103.72M |